Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or "the Company”), a clinical-stage biotechnology company developing ...
CFO Allan Kragh Thaysen has transferred 4,760 Tryg shares at DKK 162.75 for a total amount of DKK 774,690 on 17 October 2024.
GARDEN CITY, NY, Oct. 17, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH) (the "Company” or "ProPhase”), a next generation biotech, genomics, and diagnostics company, today announced ...